ag 1879 has been researched along with Acute Myelogenous Leukemia in 2 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, NK | 1 |
| Lucet, IS | 1 |
| Klinken, SP | 1 |
| Ingley, E | 1 |
| Rossjohn, J | 1 |
| Boehrer, S | 1 |
| Galluzzi, L | 1 |
| Lainey, E | 1 |
| Bouteloup, C | 1 |
| Tailler, M | 1 |
| Harper, F | 1 |
| Pierron, G | 1 |
| Adès, L | 1 |
| Thépot, S | 1 |
| Sébert, M | 1 |
| Gardin, C | 1 |
| de Botton, S | 1 |
| Fenaux, P | 1 |
| Kroemer, G | 1 |
2 other studies available for ag 1879 and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
Topics: Adenylyl Imidodiphosphate; Animals; Apoenzymes; B-Lymphocytes; Catalytic Domain; Crystallography, X- | 2009 |
Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Biomarkers, Tumor; Enzyme Acti | 2011 |